Literature DB >> 28943238

Free-fatty acid receptor-4 (FFA4) modulates ROS generation and COX-2 expression via the C-terminal β-arrestin phosphosensor in Raw 264.7 macrophages.

Ameneh Cheshmehkani1, Ilya S Senatorov1, Jyothi Dhuguru2, Ola Ghoneim2, Nader H Moniri3.   

Abstract

Agonism of the G protein-coupled free-fatty acid receptor-4 (FFA4) has been shown to promote numerous anti-inflammatory effects in macrophages that arise due to interaction with β-arrestin partner proteins. Humans express functionally distinct short and long FFA4 splice variants, such that FFA4-S signals through Gαq/11 and β-arrestin, while FFA4-L is intrinsically biased solely towards β-arrestin signaling. Recently, we and others have shown that phosphorylation of the FFA4 C-terminal tail is responsible for β-arrestin interactability and signaling. Given the significance of β-arrestin in the anti-inflammatory function of FFA4, the goal of this study was to examine the role of the C-terminal β-arrestin phosphosensor in FFA4 signaling induced by PMA and LPS in murine Raw 264.7 macrophages. Our data reveal for the first time that both FFA4 isoforms modulate PMA-induced ROS generation, and that abolishment of the FFA4-S, but not FFA4-L C-terminal phosphosensor, is detrimental to this effect. Furthermore, we show that while both isoforms reduce PMA-induced expression of COX-2, removal of the FFA4-S phosphosensor significantly decreases this response, suggesting that these effects of FFA4-S are β-arrestin mediated. On the contrary, FFA4-S, as well as the truncated C-terminal congener lacking the β-arrestin phosphosensor were both able to reduce LPS-induced NF-κB activity and ERK1/2 phosphorylation. However, FFA4-L and its corresponding mutant were incapable of modulating either, suggesting that these responses are mediated by G protein coupling. Taken together, our data reveal important structure-function and signaling differences between the two FFA4 isoforms, and for the first time link FFA4 to modulation of ROS in macrophages.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AH7614 (PubChem CID 233085).; COX-2; FFA4; Free-fatty acids; GPR120; Reactive oxygen species; TUG-891 (Pubchem CID 57522038)

Mesh:

Substances:

Year:  2017        PMID: 28943238      PMCID: PMC5705417          DOI: 10.1016/j.bcp.2017.09.008

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  43 in total

1.  GW9508, a free fatty acid receptor agonist, specifically induces cell death in bone resorbing precursor cells through increased oxidative stress from mitochondrial origin.

Authors:  Claire Philippe; Fabien Wauquier; Laurent Léotoing; Véronique Coxam; Yohann Wittrant
Journal:  Exp Cell Res       Date:  2013-08-22       Impact factor: 3.905

2.  Mechanisms of homologous and heterologous phosphorylation of FFA receptor 4 (GPR120): GRK6 and PKC mediate phosphorylation of Thr³⁴⁷, Ser³⁵⁰, and Ser³⁵⁷ in the C-terminal tail.

Authors:  Rebecca N Burns; Monalisa Singh; Ilya S Senatorov; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2014-01-08       Impact factor: 5.858

Review 3.  The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA.

Authors:  Elizabeth Oliver; Fiona McGillicuddy; Catherine Phillips; Sinead Toomey; Helen M Roche
Journal:  Proc Nutr Soc       Date:  2010-02-17       Impact factor: 6.297

Review 4.  Reactive oxygen species and oxidative stress in osteoclastogenesis, skeletal aging and bone diseases.

Authors:  Danielle A Callaway; Jean X Jiang
Journal:  J Bone Miner Metab       Date:  2015-03-26       Impact factor: 2.626

5.  Transcriptional and post-transcriptional mechanisms for lysophosphatidic acid-induced cyclooxygenase-2 expression in ovarian cancer cells.

Authors:  Regina A Oyesanya; Zendra P Lee; Jinhua Wu; Jing Chen; Yuanda Song; Abir Mukherjee; Paul Dent; Tomasz Kordula; Huiping Zhou; Xianjun Fang
Journal:  FASEB J       Date:  2008-03-24       Impact factor: 5.191

6.  Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells.

Authors:  Sailaja Paruchuri; Yongfeng Jiang; Chunli Feng; Sanjeev A Francis; Jorge Plutzky; Joshua A Boyce
Journal:  J Biol Chem       Date:  2008-04-14       Impact factor: 5.157

7.  Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120).

Authors:  Steven M Sparks; Grace Chen; Jon L Collins; Dana Danger; Steven T Dock; Channa Jayawickreme; Stephen Jenkinson; Christopher Laudeman; M Anthony Leesnitzer; Xi Liang; Patrick Maloney; David C McCoy; David Moncol; Vincent Rash; Thomas Rimele; Padmaja Vulimiri; James M Way; Sean Ross
Journal:  Bioorg Med Chem Lett       Date:  2014-05-16       Impact factor: 2.823

Review 8.  Omega-3 fatty acids and inflammatory processes.

Authors:  Philip C Calder
Journal:  Nutrients       Date:  2010-03-18       Impact factor: 6.706

9.  Reactive oxygen species induce Cox-2 expression via TAK1 activation in synovial fibroblast cells.

Authors:  Yuta Onodera; Takeshi Teramura; Toshiyuki Takehara; Kanae Shigi; Kanji Fukuda
Journal:  FEBS Open Bio       Date:  2015-06-06       Impact factor: 2.693

10.  TNF-α and LPA promote synergistic expression of COX-2 in human colonic myofibroblasts: role of LPA-mediated transactivation of upregulated EGFR.

Authors:  James Yoo; Citlali Ekaterina Rodriguez Perez; Wenxian Nie; James Sinnett-Smith; Enrique Rozengurt
Journal:  BMC Gastroenterol       Date:  2013-05-20       Impact factor: 3.067

View more
  7 in total

1.  Carboxy-Terminal Phosphoregulation of the Long Splice Isoform of Free-Fatty Acid Receptor-4 Mediates β-Arrestin Recruitment and Signaling to ERK1/2.

Authors:  Ilya S Senatorov; Ameneh Cheshmehkani; Rebecca N Burns; Kirti Singh; Nader H Moniri
Journal:  Mol Pharmacol       Date:  2020-03-04       Impact factor: 4.436

2.  Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum.

Authors:  Neha Milind Chitre; Bo Jarrett Wood; Azizi Ray; Nader H Moniri; Kevin Sean Murnane
Journal:  Neuropharmacology       Date:  2020-01-27       Impact factor: 5.250

3.  The adrenergic receptor antagonist carvedilol interacts with serotonin 2A receptors both in vitro and in vivo.

Authors:  Kevin Sean Murnane; Osman F Guner; J Phillip Bowen; Kalyn M Rambacher; Nader H Moniri; Tyler J Murphy; Cedrick Maceo Daphney; Aboagyewaah Oppong-Damoah; Kenner C Rice
Journal:  Pharmacol Biochem Behav       Date:  2019-04-15       Impact factor: 3.533

Review 4.  Signaling through Free Fatty Acid Receptor 4 Attenuates Cardiometabolic Disease.

Authors:  Timothy D O'Connell; Katherine A Murphy; Naixin Zhang; Sara J Puccini; Chastity L Healy; Brian A Harsch; Michael J Zhang; Gregory C Shearer
Journal:  Physiology (Bethesda)       Date:  2022-08-09

Review 5.  The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines.

Authors:  Ilya S Senatorov; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2018-02-13       Impact factor: 5.858

6.  Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases.

Authors:  Melanie Wannick; Siegfried Bezdek; Nathalie Guillen; Markus Thieme; Fibi Meshrkey; Sadegh Mousavi; Michaela Seeling; Falk Nimmerjahn; Attila Mócsai; Detlef Zillikens; Tanya Sezin; Christian D Sadik
Journal:  Pharmacol Res Perspect       Date:  2018-11-08

7.  Induction of Cyclooxygenase-2 by Overexpression of the Human NADPH Oxidase 5 (NOX5) Gene in Aortic Endothelial Cells.

Authors:  Javier Marqués; Adriana Cortés; Álvaro Pejenaute; Eduardo Ansorena; Gloria Abizanda; Felipe Prósper; Juan José Martínez-Irujo; Carlos de Miguel; Guillermo Zalba
Journal:  Cells       Date:  2020-03-06       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.